Clinical Trials Directory

Trials / Sponsors / Gannex Pharma Co., Ltd.

Gannex Pharma Co., Ltd.

Industry · 9 registered clinical trials.

StatusTrialPhaseStarted
WithdrawnStudy to Evaluate the Safety, Tolerability, and Efficacy of ASC41 in Adults With NASH
Nonalcoholic Steatohepatitis (NASH)
Phase 22023-12-01
Active Not RecruitingStudy to Evaluate the Safety, Tolerability, and Efficacy of ASC41 Tablets in Adult Patients With NASH
Non-alcoholic Fatty Liver Disease, Non-alcoholic Steatohepatitis
Phase 22022-09-30
CompletedDrug Interaction Study of ASC42 With Atorvastatin
Healthy
Phase 12022-08-08
CompletedStudy to Evaluate the Safety and Efficacy of ASC42 Tablets in Subjects With Primary Biliary Cholangitis
Primary Biliary Cholangitis
Phase 22022-04-06
CompletedSafety, Tolerability, and Pharmacokinetics of ASC43F, a Fixed Dose Combination Tablet in Healthy Subjects
Healthy Volunteer
Phase 12021-11-01
CompletedDDI Study of ASC41 in HV and the PK, Safety and Tolerability in Subjects With NAFLD.
Healthy, NAFLD
Phase 12021-03-16
CompletedStudy to Evaluate the Effect of Food on the Pharmacokinetics of ASC41 in Healthy Volunteers
Healthy, NAFLD, Hyperlipidemia
Phase 12020-12-27
CompletedStudy to Evaluate the Safety and Efficacy of ASC41 in Overweight and Obese Subjects
Overweight and Obesity, NAFLD, Hyperlipidemia
Phase 12020-12-22
CompletedStudy to Evaluate Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of ASC42 in Healthy Subjects
Healthy
Phase 12020-11-30